Page 15 - Read Online

Kyriazis. J Transl Genet Genom 2018;2:7. I https://doi.org/10.20517/jtgg.2018.04 Page 7 of 8

Consent for publication
Not applicable.

Copyright
© The Author(s) 2018.

REFERENCES
1. Liu JP. Molecular mechanisms of ageing and related diseases. Clin Exp Pharmacol Physiol 2014;41:445-58.
2. Goldsmith TC. Evolution of aging theories: why modern programmed aging concepts are transforming medical research. Biochemistry
(Mosc) 2016;81:1406-12.
3. Vaiserman AM. Aging-modulating treatments: from reductionism to a system-oriented perspective. Front Genet 2014;5:446.
4. Kyriazis M. Third phase science: defining a novel model of research into human ageing. Front Biosci (Landmark Ed) 2017;22:982-90.
5. Kyriazis M. Editorial: Re-thinking ageing: a cross-disciplinary perspective (a new era for ageing). Mech Ageing Dev 2017;163:1.
6. Cabrera D, Cabrera L. Systems thinking made simple: new hope for solving wicked problems. Ithaca, NY: Odyssean; 2015.
7. Asensio-Sánchez VM. Dracula was right: the elixir of youth could be the young blood. Arch Soc Esp Oftalmol 2015;90:453.
8. Elghblawi E. Platelet-rich plasma, the ultimate secret for youthful skin elixir and hair growth triggering. J Cosmet Dermatol 2018;17:423-
30.
9. Girgis CM. Vitamin D and muscle function in the elderly: the elixir of youth? Curr Opin Clin Nutr Metab Care 2014;17:546-50.
10. Andersen RE, Lim DA. An ingredient for the elixir of youth. Cell Res 2014;24:1381-2.
11. Check Hayden E. Anti-ageing pill pushed as bona fide drug. Nature 2015;522:265-6.
12. Bhullar KS, Hubbard BP. Lifespan and healthspan extension by resveratrol. Biochim Biophys Acta 2015;1852:1209-18.
13. Kumar S, Lombard DB. Finding Ponce de Leon’s Pill: challenges in screening for anti-aging molecules. F1000Res 2016;5:F1000 Faculty
Rev-406.
14. Cottin Y, Rochette L. A member of the TGF-β superfamily, GDF11: functions in the cardiac regeneration, perhaps an “elixir of youth?”.
Arch Cardiovasc Dis 2015;108:409-11.
15. Lucke JC, Diedrichs PC, Partridge B, Hall WD. Anticipating the anti-ageing pill. Lessons from the history of the oral contraceptive pill and
hormone replacement therapy. EMBO Rep 2009;10:108-13.
16. Wagner G. Towards a life prolonging pill? Small molecules with anti-ageing properties. Curr Drug Targets 2006;7:1531-7.
17. Blagosklonny MV. An anti-aging drug today: from senescence-promoting genes to anti-aging pill. Drug Discov Today 2007;12:218-24.
18. Zealley B, de Grey ADNJ. Commentary on some recent theses relevant to combating aging: February 2018. Rejuvenation Res 2018;21:70-
6.
19. Kyriazis M, Apostolides A. The fallacy of the longevity elixir: negligible senescence may be achieved, but not by using something physical.
Curr Aging Sci 2015;8:227-34.
20. Kyriazis M. The impracticality of biomedical rejuvenation therapies: translational and pharmacological barriers. Rejuvenation Res
2014;17:390-6.
21. Callahan CM, Foroud T, Saykin AJ, Shekhar A, Hendrie HC. Translational research on aging: clinical epidemiology as a bridge between the
sciences. Transl Res 2014;163:439-45.
22. Henney AM. The promise and challenge of personalized medicine: aging populations, complex diseases, and unmet medical need. Croat
Med J 2012;53:207-10.
23. de Magalhães JP. The scientific quest for lasting youth: prospects for curing aging. Rejuvenation Res 2014;17:458-67.
24. Mohler J, Najafi B, Fain M, Ramos KS. Precision medicine: a wider definition. J Am Geriatr Soc 2015;63:1971-2.
25. Reitz C. Toward precision medicine in Alzheimer’s disease. Ann Transl Med 2016;4:107.
26. Hampel H, O’Bryant SE, Castrillo JI, Ritchie C, Rojkova K, Broich K, Benda N, Nisticò R, Frank RA, Dubois B, Escott-Price V, Lista S.
Precision medicine - the golden gate for detection, treatment and prevention of Alzheimer’s disease. J Prev Alzheimers Dis 2016;3:243-59.
27. Zhu Y, Tchkonia T, Pirtskhalava T. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 2015;14:644-58.
28. Roos CM, Zhang B, Palmer AK. Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice.
Aging Cell 2016;15:973-7.
29. Zhu Y, Tchkonia T, Fuhrmann-Stroissnigg H. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-
apoptotic factors. Aging Cell 2016;15:428-35.
30. Rahnasto-Rilla M, Tyni J, Huovinen M, Jarho E, Kulikowicz T, Ravichandran S, A Bohr V, Ferrucci L, Lahtela-Kakkonen M, Moaddel R.
Natural polyphenols as sirtuin 6 modulators. Sci Rep 2018;8:4163.
31. Kraig E, Linehan LA, Liang H, Romo TQ, Liu Q, Wu Y, Benavides AD, Curiel TJ, Javors MA, Musi N, Chiodo L, Koek W, Gelfond
JAL, Kellogg DL Jr. A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort:
Immunological, physical performance, and cognitive effects. Exp Gerontol 2018;105:53-69.
32. Ratho L, Pant A, Awasthi H. An antidiabetic polyherbal phytomedicine confers stress resistance and extends lifespan in Caenorhabditis
elegans. Biogerontology 2017;18:131-47.
33. Barzilai N, Crandall JP, Kritchevsky SB. Metformin as a tool to target aging. Cell Metab 2016;23:1060-5.
34. Strazhesko ID, Tkacheva ON, Akasheva DU. Atorvastatin therapy modulates telomerase activity in patients free of atherosclerotic
cardiovascular diseases. Front Pharmacol 2016;7:347.
35. Kyriazis M. Translating laboratory anti-aging biotechnology into applied clinical practice: problems and obstacles. World J Transl Med
2015;4:51-4.